| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | BMJ, The | 2009 | 9.7K |
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | BMJ, The | 2008 | 9.6K |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | PLoS Medicine | 2009 | 9.1K |
| Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis | New England Journal of Medicine | 1991 | 7.1K |
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | New England Journal of Medicine | 2000 | 6.9K |
| The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee | Arthritis and Rheumatism | 1990 | 6.5K |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Journal of Clinical Epidemiology | 2009 | 6.1K |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation | BMJ, The | 2015 | 5.8K |
| PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation | Annals of Internal Medicine | 2018 | 5.6K |
| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 | Critical Care Medicine | 2013 | 4.9K |
| Scoping studies: advancing the methodology | Implementation Science | 2010 | 4.7K |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
| GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables | Journal of Clinical Epidemiology | 2011 | 4.5K |
| Telomeres shorten during ageing of human fibroblasts | Nature | 1990 | 4.5K |
| ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions | BMJ, The | 2016 | 4.4K |
| Using SeDuMi 1.02, A Matlab toolbox for optimization over symmetric cones | Optimization Methods and Software | 1999 | 4.3K |
| Development and reliability of a system to classify gross motor function in children with cerebral palsy | Developmental Medicine and Child Neurology | 1997 | 4.1K |
| GRADE guidelines: 3. Rating the quality of evidence | Journal of Clinical Epidemiology | 2011 | 3.9K |
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) | American Journal of Industrial Medicine | 1996 | 3.4K |
| Simulations of the formation, evolution and clustering of galaxies and quasars | Nature | 2005 | 3.4K |
| Measurement of health status. Ascertaining the minimal clinically important difference | Contemporary Clinical Trials | 1989 | 3.2K |
| Edoxaban versus warfarin in patients with atrial fibrillation | New England Journal of Medicine | 2013 | 3.2K |
| Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 | Intensive Care Medicine | 2017 | 3.2K |
| Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report | Chest | 2016 | 3.1K |
